Pinion John Richard Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$2.66M

Insider Activity of Pinion John Richard

According to the SEC Form 4 filings, Pinion John Richard, being in a position of

  1. See Remarks at Ultragenyx Pharmaceutical Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10029 shares for $228,661,
    over all time since 2019-03-05, has bought 0 shares, and sold 49589 shares for $2.89M.

Biography of Pinion John Richard

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$228,6611100

Comparison of Insiders on Amount of Buys and Sells

2026-03-02SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
10,029
0.0101%
$22.80$228,661+3%
2025-03-03SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
14,439
0.016%
$42.10$607,882-20.43%
2024-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
4,173
0.0051%
$53.76$224,340-15.68%
2023-05-18SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
2,012
0.0028%
$50.00$100,600-14.32%
2023-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
3,755
0.0053%
$45.26$169,951-7.58%
2022-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
4,498
0.0064%
$66.62$299,657-29.29%
2021-10-14SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
358
0.0005%
$81.14$29,048-17.23%
2021-05-06SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
363
0.0005%
$113.69$41,269-29.17%
2021-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
6,198
0.009%
$138.17$856,378-38.37%
2020-10-14SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
262
0.0004%
$88.00$23,056+15.06%
2020-10-12SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
2,780
0.0043%
$94.47$262,627+11.68%
2019-03-05SaleUltragenyx Pharmaceutical Inc.
RARE
See Remarks
722
0.0013%
$65.52$47,305-13.14%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.